Discover how Quantum recalibrates GLP-1 receptors, boosts mitochondrial output, and reduces metabolic inflammation to restore healthy weight-loss signaling.

Explore how retatrutide, a triple agonist targeting GLP-1, GIP, and glucagon receptors, drives weight loss. Learn trial results, safety questions, and how it compares to semaglutide and tirzepatide.

GLP-1 receptor agonists like semaglutide and tirzepatide are powerful weight-loss tools, but studies show lean mass can be lost along with fat. This article reviews the evidence and provides a muscle preservation plan using protein, resistance training, and supportive peptides or hormones.

Microdosing GLP-1s like semaglutide and tirzepatide is emerging as a trend, with claims of fewer side effects and steady appetite control. While the theory sounds appealing, human data on microdosing is limited, and risks may outweigh benefits without proper medical oversight.